An increased fetal nuchal translucency detected by first trimester ultrasound has been associated with an elevated risk of aneuploidy. The etiology of the increased nuchal translucency in fetuses with normal chromosomes is uncertain, but it has been associated with poor pregnancy outcome. We report a fetus with increased nuchal translucency and a normal karyotype, in which parvovirus was detected by polymerase chain reaction in the amniotic fluid. Although an ultrasound detected an increased nuchal fold thickness in the second trimester, the pregnancy was otherwise uncomplicated. Parvovirus should be considered as a possible etiology of increased nuchal translucency. The risks to a fetus with first trimester parvovirus infections diagnosed under these conditions are uncertain and require larger studies. Journal of Perinatology 2000; 2:129-131.
Fetal nuchal translucencies have been associated with abnormal fetal karyotype 1 and have been proposed to be a possible first trimester screening tool for fetal aneuploidy. 2 Those pregnancies in which fetuses have normal chromosomes are still at risk for anomalies and antepartum complications. 3 The exact etiology of the translucency is uncertain but has been related to either abnormal lymphatic development 4 or cardiac abnormalities. 5 Others have ascribed it to infections but considered them to be an unlikely cause. 6 Parvovirus has been associated with fetal ascites in the second and third trimester. 7 Hydrops is felt to be due to severe fetal anemia or myocarditis. 8 Although not common, first trimester infection has been associated with spontaneous abortion. 9 The manifestations of first trimester infections are uncertain but in theory could result in increased nuchal translucency. We report a case of a patient whose fetus had an increased nuchal translucency and the presence of parvovirus in the amniotic fluid.
CASE REPORT
A 28-year-old gravida 3, para G2P1 underwent a transvaginal ultrasound at 11 weeks 5 days. The crown-rump length was 59 mm, consistent with 12 weeks 2 days. A nuchal translucency of 3.7 mm was noted ( Figure 1 ). The fetal pole otherwise appeared normal, and the fetal heart rate was 161 beats per minute. The patient stated that at ϳ5 to 6 weeks' gestation she was exposed to a child with a high fever and a rash. A genetic amniocentesis was performed at 15 weeks, and fluid was sent for cytogenetics and polymerase chain reaction studies for parvovirus. The chromosomes were consistent with a normal male karyotype. The amniotic fluid polymerase chain reaction studies detected the presence of parvovirus. At 17 weeks' gestation, after the positive amniotic fluid parvoviral result, maternal serology was sent for IgG and IgM antibodies to parvovirus. The maternal serology testing noted no evidence of IgM antibodies, but IgG antibodies to parvovirus were present.
The patient was followed with serial fetal ultrasounds that were only significant for an increased nuchal fold. The nuchal fold measured 8 mm at 15 weeks ( Figure 2 ). There was never any evidence of hydrops or growth restriction. Clinical Perinatal/Neonatal Case Presentation
At 37 weeks' gestation, the patient presented complaining of decreased fetal movements. Labor was induced and the patient had a vaginal delivery of a male infant weighing 3509 gm with Apgars of 8 and 9 at 1 and 5 minutes, respectively. Examination of the infant noted redundant nuchal skin (Figure 3) . The infant had a normal course in the nursery; however, phenylketonuria was diagnosed on routine neonatal testing. He was placed on a low phenolalanine diet, and at 4 months of life was doing well.
CONCLUSION
With heightened attention to first trimester ultrasound evaluation for evidence of fetal aneuploidy, a number of fetuses will be detected with increased nuchal translucency. The implications of this finding in association with a normal fetal karyotype are uncertain at this time. Several studies have reported poor pregnancy outcomes even in those fetuses without karyotypic abnormalities. 3, 10 The poor outcomes seem to be due mostly to structural abnormalities or spontaneous abortions. A recent report investigated the need to screen for infections in pregnancies complicated by increased fetal nuchal translucency. Sebire et al. 6 were the first to document a case of increased nuchal translucency associated with a parvoviral infection. Their study involved testing all pregnancies with increased nuchal translucencies and normal karyotypes for cytomegalovirus, toxoplasmosis, and parvoviral infections. They found only a single case of parvoviral infection and only a 1.4% overall incidence rate of these infections. All of these cases resulted in the delivery of healthy infants. 6 They concluded that the rate of maternal infection in pregnancies complicated by a fetal nuchal translucency was similar to the general population and that, therefore, screening for these maternal infections was not necessary.
However, the authors in this study used maternal serology only as evidence of a recent infection. Several other studies have documented the presence of parvovirus in maternal and fetal samples using polymerase chain reaction even when IgM antibodies to parvovirus were absent. [11] [12] [13] Thus, as is seen in our case report, parvovirus can be detected in the amniotic fluid even when IgM to parvovirus is not detected in maternal serum. This is the second case report that documents a fetal parvoviral infection in association with an increased nuchal translucency. Other investigators have also reported three fetuses with first trimester hydrops associated with parvovirus based on the presence of specific IgM antibodies in maternal serum. Of interest is that all three of these pregnancies resulted in the delivery of healthy infants. Thus, of the five fetuses with either an increased nuchal translucency or hydrops in the first trimester, all had a favorable outcome.
It may be reasonable to offer screening for parvovirus antibodies to women whenever increased fetal nuchal translucency is noted. If IgG is present and the patient elects to have an amniocentesis, polymerase chain reaction testing for parvovirus should be obtained. The presence of virus could explain the ultrasound findings and provide some maternal reassurance that a favorable outcome is possible.
